Matrifen [fentanyl] for therapy of severe, chronic pain
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2013
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms MATRIX II
- Sponsors Takeda Pharmaceuticals International GmbH
- 07 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jan 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 20 Nov 2007 New trial record.